Introduction:
Dr. Kimo Bachiashvili graduated from Tbilisi State Medical University in 2007. He then moved to the SUNY Upstate Medical University in Syracuse, New York as a Research Assistant in Dr. Timothy Damron’s laboratory. There he studied the role of hedgehog pathway inhibition in human alveolar rhabdomyosarcoma. He then started Medicine residency in Yale-New Haven Hospital in New Haven, Connecticut which he graduated in 2015. During residency, he focused on the CREB pathway as a target in AML while working in Dr. Stephanie Halene’s laboratory. During residency, he received Intern of the Year Elected by Peers award in 2013, Excellence in Ambulatory Care award in 2014, and Outstanding Efforts in Research award in 2015. After graduation in 2015, he joined Hematology and Oncology fellowship program in the Montefiore Medical Center / Albert Einstein College of Medicine in Bronx, New York under directorship of Dr. Rasim Gucalp. His research focus during fellowship was TGF-beta signaling in low-grade MDS which he conducted in Dr. Amit Verma’s laboratory. He also served as a Chief fellow in the last year of training: 2017-2018 academic year. In 2018, he received Outstanding Achievement in the Teaching of Medical Students award by Leo M. Davidoff Society of the Albert Einstein College of Medicine. In August 2018, Dr. Kimo Bachiashvili joined UAB, Division of Hematology and Oncology as a faculty. Dr. Kimo Bachiashvili is an assistant professor at the University of Alabama at Birmingham, in the Division of Hematology and Oncology. His clinical interests include Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia.
Clinical Interests:
His clinical interests include Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia.
Research:
1. Characterization of the MDS abnormal clone
2. Alteration of bone marrow microenvironment in MDS
3. Acute Myeloid Leukemia therapy in the elderly
